Neurotechnology In Brief
This article was originally published in The Gray Sheet
Executive Summary
Neurodevices show growth: Neurodevices generated $7.1 billion in global revenue in 2009, a 15% jump over the previous year, according to neurotech consulting firm NeuroInsights. Neurodiagnostics revenue, on the other hand, dropped 11% year-over-year, to $15 billion. But the neurotechnology field as a whole remained an attractive investment, with the broader sector garnering $1.58 billion in venture capital investment during the year, up 9.5%. The investment activity comes as brain-related illness remains the largest unmet medical need, with 2 billion people affected worldwide, according to NeuroInsights. The findings were included in NeuroInsights' Neurotechnology Industry 2010 Report, highlights of which were presented May 19 at the Neurotech Investing and Partnering Conference in Boston